NCT03418714View on ClinicalTrials.gov

Effects of Salvinorin A on Brain Function

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 14, 2017

Primary Completion Date

March 2, 2020

Study Completion Date

March 2, 2020

Conditions
Drug Effect
Interventions
DRUG

Salvinorin A

Salvinorin A, blinded doses

Trial Locations (1)

21224

Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER

NCT03418714 - Effects of Salvinorin A on Brain Function | Biotech Hunter | Biotech Hunter